Neurosense TherapeuticsNRSN
13F holders, Q1 2024 (March 31)8holders
1famous investor
$1.82avg. 13F price*
At the end of Q1 2024, 8 institutions reported holding Neurosense Therapeutics Ltd. (NRSN) in their 13F filings. The largest holders were Renaissance Technologies ($129K), Meitav Investment House Ltd. ($91K) and Woodline Partners LP ($36K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Neurosense Therapeutics Ltd.
- CUSIP
- M74240108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $165K |
| Exits | 2 | $20K |
Ownership 8 holders
| Renaissance Technologies | 0.00% | New | 71,100 | $129K |
| Meitav Investment House Ltd. | 0.00% | Reduce -47.4% | 50,000 | $91K |
| Woodline Partners LP | 0.00% | New | 19,581 | $36K |
| Geode Capital Management, LLC | 0.00% | No change | 11,963 | $22K |
| UBS Group AG | 0.00% | Add +117.0% | 11,928 | $22K |
| Morgan Stanley | 0.00% | No change | 1,500 | $3K |
| Cwm, LLC | 0.00% | No change | 1,000 | $2K |
| Qube Research & Technologies Ltd | 0.00% | No change | 54 | $98 |
"% of holder's portfolio" is NRSN's weight in each manager's 13F, not the share of Neurosense Therapeutics Ltd. the manager owns.